Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection
暂无分享,去创建一个
[1] Yan He,et al. Siderophore Biosynthesis Governs the Virulence of Uropathogenic Escherichia coli by Coordinately Modulating the Differential Metabolism. , 2016, Journal of proteome research.
[2] Eric P. Skaar,et al. Metals in infectious diseases and nutritional immunity. , 2015, Metallomics : integrated biometal science.
[3] S. Sheppard,et al. Variation in Siderophore Biosynthetic Gene Distribution and Production across Environmental and Faecal Populations of Escherichia coli , 2015, PloS one.
[4] D. Rasko,et al. Host-specific induction of Escherichia coli fitness genes during human urinary tract infection , 2014, Proceedings of the National Academy of Sciences.
[5] C. Dozois,et al. Iron, copper, zinc, and manganese transport and regulation in pathogenic Enterobacteria: correlations between strains, site of infection and the relative importance of the different metal transport systems for virulence , 2013, Front. Cell. Infect. Microbiol..
[6] D. Rasko,et al. Draft genome sequences of five recent human uropathogenic Escherichia coli isolates. , 2013, Pathogens and disease.
[7] A. Spivak,et al. Urinary tract infections: current and emerging management strategies. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] H. Mobley,et al. Immunization with the Yersiniabactin Receptor, FyuA, Protects against Pyelonephritis in a Murine Model of Urinary Tract Infection , 2013, Infection and Immunity.
[9] Eric P. Skaar,et al. Iron in infection and immunity. , 2013, Cell host & microbe.
[10] G. H. Reed,et al. The ubiquity of iron. , 2012, ACS chemical biology.
[11] H. Mobley,et al. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine , 2012, Expert review of vaccines.
[12] C. Dozois,et al. The Ins and Outs of siderophore mediated iron uptake by extra-intestinal pathogenic Escherichia coli. , 2011, Veterinary microbiology.
[13] T. D. de Reijke,et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. , 2011, Archives of internal medicine.
[14] C. Dozois,et al. Klebsiella pneumoniae Yersiniabactin Promotes Respiratory Tract Infection through Evasion of Lipocalin 2 , 2011, Infection and Immunity.
[15] C. Dozois,et al. Secretion, but not overall synthesis, of catecholate siderophores contributes to virulence of extraintestinal pathogenic Escherichia coli , 2011, Molecular microbiology.
[16] C. Alteri,et al. Identification of In Vivo-Induced Antigens Including an RTX Family Exoprotein Required for Uropathogenic Escherichia coli Virulence , 2011, Infection and Immunity.
[17] Richard Colgan,et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] H. Mobley,et al. Redundancy and Specificity of Escherichia coli Iron Acquisition Systems during Urinary Tract Infection , 2011, Infection and Immunity.
[19] Betsy Foxman,et al. The epidemiology of urinary tract infection , 2010, Nature Reviews Urology.
[20] D. Rasko,et al. Escherichia coli Global Gene Expression in Urine from Women with Urinary Tract Infection , 2010, PLoS pathogens.
[21] H. Mobley,et al. Waging War against Uropathogenic Escherichia coli: Winning Back the Urinary Tract , 2009, Infection and Immunity.
[22] A. Marchese,et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. , 2009, International journal of antimicrobial agents.
[23] C. Alteri,et al. Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract Infection , 2009, PLoS pathogens.
[24] H. Mobley,et al. Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics. , 2009, Journal of microbiological methods.
[25] R. Bergeron,et al. Vibriobactin antibodies: a vaccine strategy. , 2009, Journal of medicinal chemistry.
[26] A. Nicolau,et al. Antibiotherapy and pathogenesis of uncomplicated UTI: difficult relationships , 2009, Journal of applied microbiology.
[27] C. Alteri,et al. Fitness of Escherichia coli during Urinary Tract Infection Requires Gluconeogenesis and the TCA Cycle , 2009, PLoS pathogens.
[28] H. Mobley,et al. Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection , 2009, Molecular microbiology.
[29] W. Hörl,et al. Current concepts of molecular defence mechanisms operative during urinary tract infection , 2008, European journal of clinical investigation.
[30] T. J. Wiles,et al. Origins and virulence mechanisms of uropathogenic Escherichia coli. , 2008, Experimental and molecular pathology.
[31] P. Humphrey,et al. Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection , 2007, PLoS medicine.
[32] M. Marahiel,et al. Siderophore-Based Iron Acquisition and Pathogen Control , 2007, Microbiology and Molecular Biology Reviews.
[33] B. Foxman,et al. Antibiotic resistance and pyelonephritis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] M. Guzmán,et al. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[35] C. Alteri,et al. Quantitative Profile of the Uropathogenic Escherichia coli Outer Membrane Proteome during Growth in Human Urine , 2007, Infection and Immunity.
[36] J. Karlowsky,et al. Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study , 2006, Antimicrobial Agents and Chemotherapy.
[37] L. Nicolle,et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). , 2005, International journal of antimicrobial agents.
[38] H. Mobley,et al. The IrgA Homologue Adhesin Iha Is an Escherichia coli Virulence Factor in Murine Urinary Tract Infection , 2005, Infection and Immunity.
[39] Shizuo Akira,et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.
[40] H. Mobley,et al. Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection , 2004, Infection and Immunity.
[41] M. Footer,et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] H. Mobley,et al. Development of an Intranasal Vaccine To Prevent Urinary Tract Infection by Proteus mirabilis , 2004, Infection and Immunity.
[43] G. Leverson,et al. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. , 2003, The Journal of urology.
[44] T. Russo,et al. IroN Functions as a Siderophore Receptor and Is a Urovirulence Factor in an Extraintestinal Pathogenic Isolate of Escherichia coli , 2002, Infection and Immunity.
[45] R. Strong,et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.
[46] A. Torres,et al. TonB-Dependent Systems of Uropathogenic Escherichia coli: Aerobactin and Heme Transport and TonB Are Required for Virulence in the Mouse , 2001, Infection and Immunity.
[47] T. Hooton,et al. Increasing Antimicrobial Resistance and the Management of Uncomplicated Community-Acquired Urinary Tract Infections , 2001, Annals of Internal Medicine.
[48] C. Janeway,et al. Adaptive Immunity to Infection , 2001 .
[49] D. Le Roy,et al. Results of passive and active immunization directed against ferric aerobactin in experimental enterobacterial infections in mice and chickens. , 1995, Research in microbiology.
[50] J. Buyer,et al. A Method for Detection of Pseudobactin, the Siderophore Produced by a Plant-Growth-Promoting Pseudomonas Strain, in the Barley Rhizosphere , 1993, Applied and environmental microbiology.
[51] D. Le Roy,et al. Comparison of chemical assay, bioassay, enzyme-linked immunosorbent assay, and dot blot hybridization for detection of aerobactin in members of the family Enterobacteriaceae , 1993, Applied and environmental microbiology.
[52] D. Le Roy,et al. Activity and specificity of a mouse monoclonal antibody to ferric aerobactin , 1992, Infection and immunity.
[53] E. Graves. National Hospital Discharge Survey. , 1989, Vital and health statistics. Series 13, Data from the National Health Survey.
[54] Urinary albumin, transferrin and iron excretion in diabetic patients. , 1991, Kidney international.
[55] H. Tammen. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. The German Urinary Tract Infection Study Group. , 1990, British journal of urology.
[56] J. G. Michael,et al. Cationization of protein antigens. II. Alteration of regulatory properties. , 1987, Journal of immunology.
[57] C. Bolin,et al. Passive immunization with antibodies against iron-regulated outer membrane proteins protects turkeys from Escherichia coli septicemia , 1987, Infection and immunity.
[58] J. G. Michael,et al. Cationization of protein antigens. I. Alteration of immunogenic properties. , 1987, Journal of immunology.
[59] J. G. Michael,et al. Cationic antigens. Problems associated with measurement by ELISA. , 1986, Journal of immunological methods.
[60] R. Freter,et al. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.
[61] E. Kamil,et al. Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. , 1982, The Journal of clinical investigation.